Wednesday, February 8, 2012

Studying Hyperbaric Oxygen and Mystery Ointment in Tulsa, Oklahoma

We always enjoy seeing a hyperbaric oxygen treatment center win some choice local media coverage. This story, about St John Wound Center in Tulsa, Oklahoma, earns bonus points for plugging a clinical trial of the mystery ointment Nexigone. It's a simple misspelling. Mystery solved. With a little googling we dug up Nexagon, whose active ingredient is
... a natural, unmodified antisense oligonucleotide that down-regulates the key gap junction protein connexin43 to dampen inflammatory responses and enhance healing.
They call it a gap junction modulator. Any questions? Learn more on the CoDa Therapeutics website. lists eight Nexagon studies completed, recruiting, or in the works.

We also note that St John has not yet made our Oklahoma treatment center directory. Come on now, everybody. It's as easy as 3-2-1.

[Photo: News On 6, Tulsa]

No comments:

Post a Comment